MDS Inc. Completes Divestiture of MDS Pharma Services Early Stage Business
March 08 2010 - 8:00AM
PR Newswire (US)
TORONTO, March 8 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a leading provider of products and services to the
global health sciences markets, today announced that it has
completed the divestiture of its MDS Pharma Services Early Stage
business. "The completion of this transaction marks the end of the
Company's strategic repositioning and enables us to move forward
with a focus on MDS Nordion," said Steve West, Chief Executive
Officer of MDS Inc. "We are committed to serving our customers by
further building our leadership positions in medical imaging and
radiotherapeutics, and sterilization technologies." MDS is
providing transition services to the buyers of the businesses it
has sold and has initiated the relocation of its corporate
headquarters to Ottawa. These activities are expected to be
substantially complete by the end of 2010. In addition, the
divestiture of the MDS Pharma Services Early Stage business does
not include the facility in Montreal, Canada, which is expected to
be closed by the end of February 2011. MDS Strategic Repositioning
Background materials pertaining to the new strategic direction for
MDS Inc. can be found on MDS Inc.'s Website at
http://www.mdsinc.com/strategic_repositioning_of_mds/index.asp.
About MDS MDS Inc. (TSX: MDS; NYSE: MDZ) is a global health science
company that provides market-leading products and services used for
the prevention, diagnosis and treatment of disease. We are a
leading provider of innovative technologies for use in medical
imaging and radiotherapeutics, and sterilization technologies
benefiting the lives of millions of people in more than 70
countries around the world. Our products and services are used
daily by pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. MDS
has more than 850 highly skilled people in five locations. Find out
more at http://www.mdsinc.com/ or http://www.mdsnordion.com/.
DATASOURCE: MDS Inc. CONTACT: MEDIA: Janet Ko, (905) 267-4226,
janet.ko@mdsinc.com;INVESTORS: Catherine Love, (905) 267-4230,
catherine.love@mdsinc.com
Copyright
Mediazest (LSE:MDZ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mediazest (LSE:MDZ)
Historical Stock Chart
From Sep 2023 to Sep 2024